A roundup of five recent RECOVER studies, including findings that Paxlovid showed limited effectiveness at preventing Long COVID onset (though it helped some cognitive/fatigue symptoms), that smell and taste changes are more common than previously recognized, and that obesity may shape which symptoms patients experience.